{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:52:53Z","timestamp":1791395573469,"version":"4.3.3"},"reference-count":110,"publisher":"Bentham Science Publishers Ltd.","issue":"3","funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science KAKENHI","doi-asserted-by":"publisher","award":["21K06591"],"award-info":[{"award-number":["21K06591"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDRR"],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Methamphetamine (METH) is classified as a Schedule II stimulant drug\nunder the United Nations Convention on Psychotropic Substances of 1971. METH and other amphetamine\nanalogues (AMPHs) are powerful addictive drugs. Treatments are needed to treat the\nsymptoms of METH addiction, chronic METH use, and acute METH overdose. No effective\ntreatment for METH abuse has been established because alterations of brain functions under the\nexcessive intake of abused drug intake are largely irreversible due in part to brain damage that\noccurs in the course of chronic METH use.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>Modulation of brain histamine neurotransmission is involved in several neuropsychiatric\ndisorders, including substance use disorders. This review discusses the possible mechanisms\nunderlying the therapeutic effects of histamine H3 receptor antagonists on symptoms of methamphetamine\nabuse.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Treatment of mice with centrally acting histamine H3 receptor antagonists increases\nhypothalamic histamine contents and reduces high-dose METH effects while potentiating lowdose\neffects via histamine H1 receptors that bind released histamine. On the basis of experimental\nevidence, it is hypothesized that histamine H3 receptors may be an effective target for the treatment\nMETH use disorder or other adverse effects of chronic METH use.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/2589977514666220414122847","type":"journal-article","created":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T08:09:31Z","timestamp":1650269371000},"page":"162-170","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Are Histamine H3 Antagonists the Definitive Treatment for Acute Methamphetamine\nIntoxication?"],"prefix":"10.2174","volume":"14","author":[{"given":"Nobue","family":"Kitanaka","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Hyogo College of Medicine, Hyogo 663-8501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9938-8508","authenticated-orcid":true,"given":"Junichi","family":"Kitanaka,","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Hyogo College of Medicine, Hyogo 663-8501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Scott","family":"Hall","sequence":"additional","affiliation":[{"name":"Department of Pharmacology\nand Experimental Therapeutics, College of Pharmacy and Pharmaceutical Sciences, University of Toledo, Toledo, Ohio\n43614, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koh-ichi","family":"Tanaka,","sequence":"additional","affiliation":[{"name":"Division of Pharmacology, Department of Pharmacy, School of Pharmacy, Hyogo University of Health\nSciences, Hyogo 650-8530, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Tomita","sequence":"additional","affiliation":[{"name":"Department of Applied Pharmacology, Kagoshima University Graduate School of\nMedical and Dental Sciences, Kagoshima 890-8544, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kento","family":"Igarashi","sequence":"additional","affiliation":[{"name":"Neurology and Research Services, New Mexico VA\nHealthcare System, Albuquerque, New Mexico 87108, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyoshi","family":"Nishiyama","sequence":"additional","affiliation":[{"name":"Division of Pharmacology, Department of Pharmacy, School of Pharmacy, Hyogo University of Health\nSciences, Hyogo 650-8530, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoaki","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Applied Pharmacology, Kagoshima University Graduate School of\nMedical and Dental Sciences, Kagoshima 890-8544, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George R.","family":"Uhl","sequence":"additional","affiliation":[{"name":"Neurology and Research Services, New Mexico VA\nHealthcare System, Albuquerque, New Mexico 87108, USA"},{"name":"Departments of Neurology, Neuroscience, Molecular\nGenetics and Microbiology, University of New Mexico, Albuquerque, New Mexico 87131, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","year":"2004","unstructured":"NIDA InfoFacts: Methamphetamine National Institute on Drug AbuseAvailable form: [cited 2012 Nov 21]2004"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0165-0173(93)90013-P","volume":"18","author":"Robinson T.E.","year":"1993","unstructured":"Robinson T.E.; Berridge K.C.; The neural basis of drug craving: An incentive-sensitization theory of addiction. Brain Res Brain Res Rev 1993,18(3),247-291","journal-title":"Brain Res Brain Res Rev"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1126\/science.278.5335.52","volume":"278","author":"Koob G.F.","year":"1997","unstructured":"Koob G.F.; Le Moal M.; Drug abuse: Hedonic homeostatic dysregulation. Science 1997,278(5335),52-58","journal-title":"Science"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1038\/nn1579","volume":"8","author":"Everitt B.J.","year":"2005","unstructured":"Everitt B.J.; Robbins T.W.; Neural systems of reinforcement for drug addiction: From actions to habits to compulsion. Nat Neurosci 2005,8(11),1481-1489","journal-title":"Nat Neurosci"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1001\/jama.1967.03130050039011","volume":"201","author":"Kramer J.C.","year":"1967","unstructured":"Kramer J.C.; Fischman V.S.; Littlefield D.C.; Amphetamine abuse. Pattern and effects of high doses taken intravenously. JAMA 1967,201(5),305-309","journal-title":"JAMA"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/BF00404607","volume":"11","author":"Randrup A.","year":"1967","unstructured":"Randrup A.; Munkvad I.; Stereotyped activities produced by amphetamine in several animal species and man. Psychopharmacology (Berl) 1967,11(4),300-310","journal-title":"Psychopharmacology (Berl)"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/0165-0173(86)90002-0","volume":"396","author":"Robinson T.E.","year":"1986","unstructured":"Robinson T.E.; Becker J.B.; Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evalua-tion of animal models of amphetamine psychosis. Brain Res 1986,396(2),157-198","journal-title":"Brain Res"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/j.1749-6632.1992.tb25965.x","volume":"654","author":"Sato M.","year":"1992","unstructured":"Sato M.; A lasting vulnerability to psychosis in patients with previous methamphetamine psychosis. Ann N Y Acad Sci 1992,654,160-170","journal-title":"Ann N Y Acad Sci"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1097\/00063110-199709000-00003","volume":"4","author":"Richards J.R.","year":"1997","unstructured":"Richards J.R.; Derlet R.; Duncan D.; Methamphetamine toxicity: Treatment with a benzodiazepine versus a butyrophenone. Eur J Emerg Med 1997,4(3),130-135","journal-title":"Eur J Emerg Med"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.bbr.2017.01.042","volume":"323","author":"Long J.D.","year":"2017","unstructured":"Long J.D.; Liu Y.; Jiao D.L.; The neuroprotective effect of memantine on methamphetamine-induced cognitive deficits. Behav Brain Res 2017,323,133-140","journal-title":"Behav Brain Res"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1007\/s00213-019-05221-3","volume":"236","author":"Gutierrez A.","year":"2019","unstructured":"Gutierrez A.; Regan S.L.; Hoover C.S.; Williams M.T.; Vorhees C.V.; Effects of intrastriatal dopamine D1 or D2 antagonists on methampheta-mine-induced egocentric and allocentric learning and memory deficits in Sprague-Dawley rats. Psychopharmacology (Berl) 2019,236(7),2243-2258","journal-title":"Psychopharmacology (Berl)"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1007\/s12640-019-00069-z","volume":"36","author":"Zhou M.","year":"2019","unstructured":"Zhou M.; Gong X.; Ru Q.; The neuroprotective effect of L-stepholidine on methamphetamine-induced memory deficits in Mice. Neurotox Res 2019,36(2),376-386","journal-title":"Neurotox Res"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/j.1360-0443.2009.02717.x","volume":"105","author":"Longo M.","year":"2010","unstructured":"Longo M.; Wickes W.; Smout M.; Harrison S.; Cahill S.; White J.M.; Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence. Addiction 2010,105(1),146-154","journal-title":"Addiction"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/j.1360-0443.2008.02437.x","volume":"104","author":"Shearer J.","year":"2009","unstructured":"Shearer J.; Darke S.; Rodgers C.; A double-blind, placebo-controlled trial of modafinil (200 mg\/day) for methamphetamine depend-ence. Addiction 2009,104(2),224-233","journal-title":"Addiction"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1177\/0897190011426557","volume":"24","author":"Brackins T.","year":"2011","unstructured":"Brackins T.; Brahm N.C.; Kissack J.C.; Treatments for methamphetamine abuse: A literature review for the clinician. J Pharm Pract 2011,24(6),541-550","journal-title":"J Pharm Pract"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.drugalcdep.2014.08.003","volume":"143","author":"Courtney K.E.","year":"2014","unstructured":"Courtney K.E.; Ray L.A.; Methamphetamine: An update on epidemiology, pharmacology, clinical phenomenology, and treatment literature. Drug Alcohol Depend 2014,143,11-21","journal-title":"Drug Alcohol Depend"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/j.1365-2125.2010.03639.x","volume":"69","author":"Karila L.","year":"2010","unstructured":"Karila L.; Weinstein A.; Aubin H.J.; Benyamina A.; Reynaud M.; Batki S.L.; Pharmacological approaches to methamphetamine dependence: A focused review. Br J Clin Pharmacol 2010,69(6),578-592","journal-title":"Br J Clin Pharmacol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s13643-020-01499-z","volume":"9","author":"Hamel C.","year":"2020","unstructured":"Hamel C.; Corace K.; Hersi M.; Psychosocial and pharmacologic interventions for methamphetamine addiction: Protocol for a scoping review of the literature. Syst Rev 2020,9(1),245","journal-title":"Syst Rev"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S0301-0082(00)00039-3","volume":"63","author":"Brown R.E.","year":"2001","unstructured":"Brown R.E.; Stevens D.R.; Haas H.L.; The physiology of brain histamine. Prog Neurobiol 2001,63(6),637-672","journal-title":"Prog Neurobiol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1152\/physrev.00043.2007","volume":"88","author":"Haas H.L.","year":"2008","unstructured":"Haas H.L.; Sergeeva O.A.; Selbach O.; Histamine in the nervous system. Physiol Rev 2008,88(3),1183-1241","journal-title":"Physiol Rev"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/0361-9230(91)90126-5","volume":"27","author":"Wada H.","year":"1991","unstructured":"Wada H.; Inagaki N.; Itowi N.; Yamatodani A.; Histaminergic neuron system in the brain: Distribution and possible functions. Brain Res Bull 1991,27(3-4),367-370","journal-title":"Brain Res Bull"},{"key":"ref=22","author":"Thurmond R.L.","year":"2014","unstructured":"Thurmond R.L.; Peripheral Neuronal Mechanism of Itch: Histamine and Itch. Itch: Mechanisms and Treatment 2014","journal-title":"Itch: Mechanisms and Treatment"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/S0091-6749(05)80223-4","volume":"86","author":"White M.V.","year":"1990","unstructured":"White M.V.; The role of histamine in allergic diseases. J Allergy Clin Immunol 1990,86(4 Pt 2),599-605","journal-title":"J Allergy Clin Immunol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1097\/MOG.0b013e32833f2010","volume":"26","author":"Schubert M.L.","year":"2010","unstructured":"Schubert M.L.; Gastric secretion. Curr Opin Gastroenterol 2010,26(6),598-603","journal-title":"Curr Opin Gastroenterol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/j.anai.2010.08.005","volume":"106","author":"Lieberman P.","year":"2011","unstructured":"Lieberman P.; The basics of histamine biology. Ann Allergy Asthma Immunol 2011,106(2)(Suppl.),S2-S5","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/0304-3940(83)90308-7","volume":"39","author":"Watanabe T.","year":"1983","unstructured":"Watanabe T.; Taguchi Y.; Hayashi H.; Evidence for the presence of a histaminergic neuron system in the rat brain: An immunohisto-chemical analysis. Neurosci Lett 1983,39(3),249-254","journal-title":"Neurosci Lett"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1073\/pnas.81.8.2572","volume":"81","author":"Panula P.","year":"1984","unstructured":"Panula P.; Yang H.Y.; Costa E.; Histamine-containing neurons in the rat hypothalamus. Proc Natl Acad Sci USA 1984,81(8),2572-2576","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/0306-4522(83)90264-6","volume":"9","author":"Roberts F.","year":"1983","unstructured":"Roberts F.; Calcutt C.R.; Histamine and the hypothalamus. Neuroscience 1983,9(4),721-739","journal-title":"Neuroscience"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.smrv.2010.06.004","volume":"15","author":"Thakkar M.M.","year":"2011","unstructured":"Thakkar M.M.; Histamine in the regulation of wakefulness. Sleep Med Rev 2011,15(1),65-74","journal-title":"Sleep Med Rev"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/164_2017_22","volume":"241","author":"B\u00e4hre H.","year":"2017","unstructured":"B\u00e4hre H.; Kaever V.; Analytical methods for the quantification of histamine and histamine metabolites. Handb Exp Pharmacol 2017,241,3-19","journal-title":"Handb Exp Pharmacol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/302832a0","volume":"302","author":"Arrang J.M.","year":"1983","unstructured":"Arrang J.M.; Garbarg M.; Schwartz J.C.; Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor. Nature 1983,302(5911),832-837","journal-title":"Nature"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/0306-4522(85)90233-7","volume":"15","author":"Arrang J.M.","year":"1985","unstructured":"Arrang J.M.; Garbarg M.; Schwartz J.C.; Autoregulation of histamine release in brain by presynaptic H3-receptors. Neuroscience 1985,15(2),553-562","journal-title":"Neuroscience"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1254\/jphs.FMJ06001X6","volume":"101","author":"Ogasawara M.","year":"2006","unstructured":"Ogasawara M.; Yamauchi K.; Satoh Y.; Recent advances in molecular pharmacology of the histamine systems: Organic cation trans-porters as a histamine transporter and histamine metabolism. J Pharmacol Sci 2006,101(1),24-30","journal-title":"J Pharmacol Sci"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/164_2021_447","volume":"266","author":"Naganuma F.","year":"2021","unstructured":"Naganuma F.; Yoshikawa T.; Organic cation transporters in brain histamine clearance: physiological and psychiatric implications. Handb Exp Pharmacol 2021,266,169-185","journal-title":"Handb Exp Pharmacol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/0024-3205(94)00416-1","volume":"54","author":"Takemura M.","year":"1994","unstructured":"Takemura M.; Imamura I.; Mizuguchi H.; Fukui H.; Yamatodani A.; Tissue distribution of histamine N-methyltransferase-like immunoreac-tivity in rodents. Life Sci 1994,54(15),1059-1071","journal-title":"Life Sci"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1254\/jjp.88.85","volume":"88","author":"Kitanaka N.","year":"2002","unstructured":"Kitanaka N.; Kitanaka J.; Oue T.; Tada Y.; Tanaka T.; Takemura M.; Genomic structure of the rat and mouse histamine N-methyltransferase gene. Jpn J Pharmacol 2002,88(1),85-92","journal-title":"Jpn J Pharmacol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0014-2999(02)01302-X","volume":"437","author":"Kitanaka J.","year":"2002","unstructured":"Kitanaka J.; Kitanaka N.; Tsujimura T.; Terada N.; Takemura M.; Expression of diamine oxidase (histaminase) in guinea-pig tissues. Eur J Pharmacol 2002,437(3),179-185","journal-title":"Eur J Pharmacol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1093\/oxfordjournals.jbchem.a135028","volume":"96","author":"Imamura I.","year":"1984","unstructured":"Imamura I.; Watanabe T.; Maeyama K.; Kubota A.; Okada A.; Wada H.; Effect of food intake on urinary excretions of histamine, N tau-methylhistamine, imidazole acetic acid and its conjugate(s) in humans and mice. J Biochem 1984,96(6),1931-1937","journal-title":"J Biochem"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/978-1-4419-8056-4_10","volume":"709","author":"Nuutinen S.","year":"2010","unstructured":"Nuutinen S.; Panula P.; Histamine in neurotransmission and brain diseases. Adv Exp Med Biol 2010,709,95-107","journal-title":"Adv Exp Med Biol"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nrn3526","volume":"14","author":"Panula P.","year":"2013","unstructured":"Panula P.; Nuutinen S.; The histaminergic network in the brain: Basic organization and role in disease. Nat Rev Neurosci 2013,14(7),472-487","journal-title":"Nat Rev Neurosci"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"E9532","DOI":"10.3390\/ijms21249532","volume":"21","author":"Grinchii D.","year":"2020","unstructured":"Grinchii D.; Dremencov E.; Mechanism of action of atypical antipsychotic drugs in mood disorders. Int J Mol Sci 2020,21(24),E9532","journal-title":"Int J Mol Sci"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1358\/dot.2010.46.8.1500050","volume":"46","author":"Ribolsi M.","year":"2010","unstructured":"Ribolsi M.; Magni V.; Rubino I.A.; Quetiapine fumarate for schizophrenia and bipolar disorder in young patients. Drugs Today (Barc) 2010,46(8),581-587","journal-title":"Drugs Today (Barc)"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"435","DOI":"10.2165\/11203840-000000000-00000","volume":"26","author":"Sanford M.","year":"2012","unstructured":"Sanford M.; Keating G.M.; Quetiapine: A review of its use in the management of bipolar depression. CNS Drugs 2012,26(5),435-460","journal-title":"CNS Drugs"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"e727","DOI":"10.1097\/MJT.0000000000000877","volume":"26","author":"Yang C.C.","year":"2019","unstructured":"Yang C.C.; Liang C.S.; Chu C.W.; Combination of quetiapine immediate release and xr for h1-antihistamine-refractory chronic spontaneous urticaria comorbid with depressive disorder: A case report. Am J Ther 2019,26(6),e727-e728","journal-title":"Am J Ther"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"108366","DOI":"10.1016\/j.drugalcdep.2020.108366","volume":"218","author":"Mariani J.J.","year":"2021","unstructured":"Mariani J.J.; Pavlicova M.; Jean Choi C.; Quetiapine treatment for cannabis use disorder. Drug Alcohol Depend 2021,218,108366","journal-title":"Drug Alcohol Depend"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1111\/j.1465-3362.2010.00185.x","volume":"29","author":"Ray L.A.","year":"2010","unstructured":"Ray L.A.; Heydari A.; Zorick T.; Quetiapine for the treatment of alcoholism: Scientific rationale and review of the literature. Drug Alcohol Rev 2010,29(5),568-575","journal-title":"Drug Alcohol Rev"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1178221820955185","DOI":"10.1177\/1178221820955185","volume":"14","author":"Vatsalya V.","year":"2020","unstructured":"Vatsalya V.; Kong M.; Marsano L.M.; Interaction of heavy drinking patterns and depression severity predicts efficacy of quetiapine fumarate XR in lowering alcohol intake in alcohol use disorder patients. Subst Abuse 2020,14,1178221820955185","journal-title":"Subst Abuse"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"597898","DOI":"10.3389\/fneur.2020.597898","volume":"11","author":"Kleimaker A.","year":"2020","unstructured":"Kleimaker A.; Kleimaker M.; B\u00e4umer T.; Beste C.; M\u00fcnchau A.; Gilles de la Tourette Syndrome-A disorder of action-perception integration. Front Neurol 2020,11,597898","journal-title":"Front Neurol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.neuron.2013.10.052","volume":"81","author":"Baldan L.C.","year":"2014","unstructured":"Baldan L.C.; Williams K.A.; Gallezot J.D.; Histidine decarboxylase deficiency causes tourette syndrome: Parallel findings in humans and mice. Neuron 2014,81(1),77-90","journal-title":"Neuron"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/0014-2999(81)90456-8","volume":"69","author":"Joshi V.V.","year":"1981","unstructured":"Joshi V.V.; Balsara J.J.; Jadhav J.H.; Chandorkar A.G.; Effect of L-histidine and chlorcyclizine on apomorphine-induced climbing behaviour and methamphetamine stereotypy in mice. Eur J Pharmacol 1981,69(4),499-502","journal-title":"Eur J Pharmacol"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s00011-009-0656-8","volume":"58","author":"Sakurai E.","year":"2009","unstructured":"Sakurai E.; Sakurai E.; Watanabe T.; Yanai K.; Uptake of L-histidine and histamine biosynthesis at the blood-brain barrier. Inflamm Res 2009,58(S1)(Suppl. 1),34-35","journal-title":"Inflamm Res"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.pbb.2009.10.009","volume":"94","author":"Kitanaka J.","year":"2010","unstructured":"Kitanaka J.; Kitanaka N.; Tatsuta T.; Pretreatment with l-histidine produces a shift from methamphetamine-induced stereotypical biting to persistent locomotion in mice. Pharmacol Biochem Behav 2010,94(3),464-470","journal-title":"Pharmacol Biochem Behav"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/0006-2952(79)90500-8","volume":"28","author":"Beaven M.A.","year":"1979","unstructured":"Beaven M.A.; Shaff R.E.; New inhibitors of histamine-N-methyltransferase. Biochem Pharmacol 1979,28(2),183-188","journal-title":"Biochem Pharmacol"},{"key":"ref=54","first-page":"329","volume":"6","author":"Cavallito J.C.","year":"1978","unstructured":"Cavallito J.C.; Nichol C.A.; Brenckman W.D.; Lipid-soluble inhibitors of dihydrofolate reductase. I. Kinetics, tissue distribution, and extent of metabolism of pyrimethamine, metoprine, and etoprine in the rat, dog, and man. Drug Metab Dispos 1978,6(3),329-337","journal-title":"Drug Metab Dispos"},{"key":"ref=55","first-page":"559","volume":"61","author":"Nichol C.A.","year":"1977","unstructured":"Nichol C.A.; Cavallito J.C.; Woolley J.L.; Sigel C.W.; Lipid-soluble diaminopyrimidine inhibitors of dihydrofolate reductase. Cancer Treat Rep 1977,61(4),559-564","journal-title":"Cancer Treat Rep"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.neuroscience.2007.05.006","volume":"147","author":"Kitanaka J.","year":"2007","unstructured":"Kitanaka J.; Kitanaka N.; Tatsuta T.; Morita Y.; Takemura M.; Blockade of brain histamine metabolism alters methamphetamine-induced expression pattern of stereotypy in mice via histamine H1 receptors. Neuroscience 2007,147(3),765-777","journal-title":"Neuroscience"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/0304-3940(84)90055-7","volume":"48","author":"Itoh Y.","year":"1984","unstructured":"Itoh Y.; Nishibori M.; Oishi R.; Saeki K.; Neuronal histamine inhibits methamphetamine-induced locomotor hyperactivity in mice. Neurosci Lett 1984,48(3),305-309","journal-title":"Neurosci Lett"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/0024-3205(92)90406-F","volume":"51","author":"Sakai N.","year":"1992","unstructured":"Sakai N.; Onodera K.; Maeyama K.; Yanai K.; Watanabe T.; Effects of (S)-alpha -fluoromethylhistidine and metoprine on locomotor activity and brain histamine content in mice. Life Sci 1992,51(6),397-405","journal-title":"Life Sci"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.eplepsyres.2012.03.016","volume":"101","author":"Samotaeva I.S.","year":"2012","unstructured":"Samotaeva I.S.; Birioukova L.M.; Midzyanovskaya I.S.; Kuznetsova G.D.; Bazyan A.S.; Tuomisto L.; Metoprine induced behavioral modifica-tions and brain regional histamine increase in WAG\/Rij and Wistar rats. Epilepsy Res 2012,101(1-2),148-156","journal-title":"Epilepsy Res"},{"key":"ref=60","first-page":"967","volume":"256","author":"Muroi N.","year":"1991","unstructured":"Muroi N.; Oishi R.; Saeki K.; Effect of reserpine on histamine metabolism in the mouse brain. J Pharmacol Exp Ther 1991,256(3),967-972","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=61","first-page":"821","volume":"37","author":"Zawilska J.","year":"1985","unstructured":"Zawilska J.; Nowak J.Z.; Changes in the rat brain histamine content following metoprine and other histamine-methyltransferase (HMT) in-hibitors. Pol J Pharmacol Pharm 1985,37(6),821-830","journal-title":"Pol J Pharmacol Pharm"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1007\/BF00173209","volume":"348","author":"Kathmann M.","year":"1993","unstructured":"Kathmann M.; Schlicker E.; Detzner M.; Timmerman H.; Nordimaprit, homodimaprit, clobenpropit and imetit: Affinities for H3 binding sites and potencies in a functional H3 receptor model. Naunyn Schmiedebergs Arch Pharmacol 1993,348(5),498-503","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/BF00431741","volume":"51","author":"Braestrup C.","year":"1977","unstructured":"Braestrup C.; Changes in drug-induced stereotyped behavior after 6-OHDA lesions in noradrenaline neurons. Psychopharmacology (Berl) 1977,51(2),199-204","journal-title":"Psychopharmacology (Berl)"},{"key":"ref=64","first-page":"275","volume":"40","author":"Arrang J.M.","year":"1994","unstructured":"Arrang J.M.; Pharmacological properties of histamine receptor subtypes. Cell Mol Biol 1994,40(3),275-281","journal-title":"Cell Mol Biol"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/0014-2999(85)90115-3","volume":"111","author":"Arrang J.M.","year":"1985","unstructured":"Arrang J.M.; Garbarg M.; Quach T.T.; Yeramian E.; Schwartz J.C.; Actions of betahistine at histamine receptors in the brain. Eur J Pharmacol 1985,111(1),73-84","journal-title":"Eur J Pharmacol"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"146873","DOI":"10.1016\/j.brainres.2020.146873","volume":"1740","author":"Kitanaka J.","year":"2020","unstructured":"Kitanaka J.; Kitanaka N.; Hall F.S.; In vivo evaluation of effects of histamine H3 receptor antagonists on methamphetamine-induced hyperlocomotion in mice. Brain Res 2020,1740,146873","journal-title":"Brain Res"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1124\/jpet.104.078402","volume":"313","author":"Fox G.B.","year":"2005","unstructured":"Fox G.B.; Esbenshade T.A.; Pan J.B.; Pharmacological properties of ABT-239 [4-(2-2-[(2R)-2-Methylpyrrolidinyl]ethyl-benzofuran-5-yl)benzonitrile]: II. Neurophysiological characterization and broad preclinical efficacy in cognition and schizophrenia of a potent and se-lective histamine H3 receptor antagonist. J Pharmacol Exp Ther 2005,313(1),176-190","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1007\/s11064-011-0500-8","volume":"36","author":"Kitanaka J.","year":"2011","unstructured":"Kitanaka J.; Kitanaka N.; Hall F.S.; Histamine H3 receptor agonists decrease hypothalamic histamine levels and increase stereotypical biting in mice challenged with methamphetamine. Neurochem Res 2011,36(10),1824-1833","journal-title":"Neurochem Res"},{"key":"ref=69","first-page":"83","volume":"18","author":"Kitanaka J","year":"2015","unstructured":"Kitanaka J; Kitanaka N; Takemura M; Methamphetamine-induced brain pathology and central histaminergic system. Nou21 (Brain21) 2015,18(2),83-88","journal-title":"Nou21 (Brain21)"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/sj.npp.1300380","volume":"29","author":"Munzar P.","year":"2004","unstructured":"Munzar P.; Tanda G.; Justinova Z.; Goldberg S.R.; Histamine h3 receptor antagonists potentiate methamphetamine self-administration and methamphetamine-induced accumbal dopamine release. Neuropsychopharmacology 2004,29(4),705-717","journal-title":"Neuropsychopharmacology"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/sj.npp.1301091","volume":"32","author":"Acevedo S.F.","year":"2007","unstructured":"Acevedo S.F.; de Esch I.J.; Raber J.; Sex- and histamine-dependent long-term cognitive effects of methamphetamine exposure. Neuropsychopharmacology 2007,32(3),665-672","journal-title":"Neuropsychopharmacology"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1124\/jpet.107.120311","volume":"321","author":"Medhurst A.D.","year":"2007","unstructured":"Medhurst A.D.; Atkins A.R.; Beresford I.J.; GSK189254, a novel H3 receptor antagonist that binds to histamine H3 receptors in Alz-heimer\u2019s disease brain and improves cognitive performance in preclinical models. J Pharmacol Exp Ther 2007,321(3),1032-1045","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1124\/jpet.112.194126","volume":"343","author":"Esbenshade T.A.","year":"2012","unstructured":"Esbenshade T.A.; Browman K.E.; Miller T.R.; Pharmacological properties and procognitive effects of ABT-288, a potent and selective histamine H3 receptor antagonist. J Pharmacol Exp Ther 2012,343(1),233-245","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/BF00517307","volume":"326","author":"Philippu A.","year":"1984","unstructured":"Philippu A.; Bald M.; Kraus A.; Dietl H.; In vivo release by histamine agonists and antagonists of endogenous catecholamines in the cat hy-pothalamus. Naunyn Schmiedebergs Arch Pharmacol 1984,326(2),116-123","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1159\/000125005","volume":"48","author":"Knigge U.","year":"1988","unstructured":"Knigge U.; Matzen S.; Warberg J.; Histaminergic regulation of prolactin secretion: Involvement of tuberoinfundibular dopaminergic neurons. Neuroendocrinology 1988,48(2),167-173","journal-title":"Neuroendocrinology"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.neuropharm.2015.07.006","volume":"106","author":"Aquino-Miranda G.","year":"2016","unstructured":"Aquino-Miranda G.; Escamilla-S\u00e1nchez J.; Gonz\u00e1lez-Pantoja R.; Bueno-Nava A.; Arias-Monta\u00f1o J.A.; Histamine H3 receptor activation inhib-its dopamine synthesis but not release or uptake in rat nucleus accumbens. Neuropharmacology 2016,106,91-101","journal-title":"Neuropharmacology"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/BF00167449","volume":"347","author":"Prast H.","year":"1993","unstructured":"Prast H.; Heistracher M.; Philippu A.; Modulation by dopamine receptors of the histamine release in the rat hypothalamus. Naunyn Schmiedebergs Arch Pharmacol 1993,347(3),301-305","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF01244933","volume":"93","author":"Schlicker E.","year":"1993","unstructured":"Schlicker E.; Fink K.; Detzner M.; G\u00f6thert M.; Histamine inhibits dopamine release in the mouse striatum via presynaptic H3 receptors. J Neural Transm (Vienna) 1993,93(1),1-10","journal-title":"J Neural Transm (Vienna)"},{"key":"ref=79","first-page":"271","volume":"279","author":"Ito C.","year":"1996","unstructured":"Ito C.; Onodera K.; Sakurai E.; Sato M.; Watanabe T.; Effects of dopamine antagonists on neuronal histamine release in the striatum of rats subjected to acute and chronic treatments with methamphetamine. J Pharmacol Exp Ther 1996,279(1),271-276","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.neulet.2013.07.026","volume":"552","author":"Alfaro-Rodriguez A.","year":"2013","unstructured":"Alfaro-Rodriguez A.; Alonso-Spilsbury M.; Arch-Tirado E.; Gonzalez-Pina R.; Arias-Monta\u00f1o J.A.; Bueno-Nava A.; Histamine H3 receptor activation prevents dopamine D1 receptor-mediated inhibition of dopamine release in the rat striatum: A microdialysis study. Neurosci Lett 2013,552,5-9","journal-title":"Neurosci Lett"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1124\/jpet.300.2.621","volume":"300","author":"Morisset S.","year":"2002","unstructured":"Morisset S.; Pilon C.; Tardivel-Lacombe J.; Acute and chronic effects of methamphetamine on tele-methylhistamine levels in mouse brain: Selective involvement of the D(2) and not D(3) receptor. J Pharmacol Exp Ther 2002,300(2),621-628","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.pnpbp.2018.07.019","volume":"88","author":"Gonz\u00e1lez B.","year":"2019","unstructured":"Gonz\u00e1lez B.; Torres O.V.; Jayanthi S.; The effects of single-dose injections of modafinil and methamphetamine on epigenetic and func-tional markers in the mouse medial prefrontal cortex: Potential role of dopamine receptors. Prog Neuropsychopharmacol Biol Psychiatry 2019,88,222-234","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pnpbp.2017.12.009","volume":"82","author":"Gonz\u00e1lez B.","year":"2018","unstructured":"Gonz\u00e1lez B.; Jayanthi S.; Gomez N.; Repeated methamphetamine and modafinil induce differential cognitive effects and specific his-tone acetylation and DNA methylation profiles in the mouse medial prefrontal cortex. Prog Neuropsychopharmacol Biol Psychiatry 2018,82,1-11","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.neuropharm.2011.11.004","volume":"62","author":"Aquino-Miranda G.","year":"2012","unstructured":"Aquino-Miranda G.; Osorio-Espinoza A.; Escamilla-S\u00e1nchez J.; Gonz\u00e1lez-Pantoja R.; Ortiz J.; Arias-Monta\u00f1o J.A.; Histamine H-receptors modulate depolarization-evoked [H]-noradrenaline release from rat olfactory bulb slices. Neuropharmacology 2012,62(2),1127-1133","journal-title":"Neuropharmacology"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1007\/s002109900097","volume":"360","author":"Prast H.","year":"1999","unstructured":"Prast H.; Tran M.H.; Fischer H.; Histaminergic neurons modulate acetylcholine release in the ventral striatum: Role of H3 histamine receptors. Naunyn Schmiedebergs Arch Pharmacol 1999,360(5),558-564","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1007\/s002109900098","volume":"360","author":"Prast H.","year":"1999","unstructured":"Prast H.; Tran M.H.; Lamberti C.; Histaminergic neurons modulate acetylcholine release in the ventral striatum: Role of H1 and H2 histamine receptors. Naunyn Schmiedebergs Arch Pharmacol 1999,360(5),552-557","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.neuroscience.2018.01.027","volume":"376","author":"Varaschin R.K.","year":"2018","unstructured":"Varaschin R.K.; Osterstock G.; Ducrot C.; Histamine H3 receptors decrease dopamine release in the ventral striatum by reducing the activity of striatal cholinergic interneurons. Neuroscience 2018,376,188-203","journal-title":"Neuroscience"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.neuroscience.2010.12.051","volume":"176","author":"Osorio-Espinoza A.","year":"2011","unstructured":"Osorio-Espinoza A.; Alatorre A.; Ramos-Jim\u00e9nez J.; Pre-synaptic histamine H-receptors modulate glutamatergic transmission in rat Globus pallidus. Neuroscience 2011,176,20-31","journal-title":"Neuroscience"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/sj.bjp.0704053","volume":"133","author":"Arias-Monta\u00f1o J.A.","year":"2001","unstructured":"Arias-Monta\u00f1o J.A.; Floran B.; Garcia M.; Aceves J.; Young J.M.; Histamine H(3) receptor-mediated inhibition of depolarization-induced, dopamine D(1) receptor-dependent release of [(3)H]-gamma-aminobutryic acid from rat striatal slices. Br J Pharmacol 2001,133(1),165-171","journal-title":"Br J Pharmacol"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0306-4522(97)00100-0","volume":"80","author":"Garcia M.","year":"1997","unstructured":"Garcia M.; Floran B.; Arias-Monta\u00f1o J.A.; Young J.M.; Aceves J.; Histamine H3 receptor activation selectively inhibits dopamine D1 receptor-dependent [3H]GABA release from depolarization-stimulated slices of rat substantia nigra pars reticulata. Neuroscience 1997,80(1),241-249","journal-title":"Neuroscience"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0166-4328(01)00220-0","volume":"124","author":"Son L.Z.","year":"2001","unstructured":"Son L.Z.; Yanai K.; Mobarakeh J.I.; Histamine H1 receptor-mediated inhibition of potassium-evoked release of 5-hydroxytryptamine from mouse forebrains. Behav Brain Res 2001,124(2),113-120","journal-title":"Behav Brain Res"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"8704","DOI":"10.1523\/JNEUROSCI.2690-04.2004","volume":"24","author":"Threlfell S.","year":"2004","unstructured":"Threlfell S.; Cragg S.J.; Kall\u00f3 I.; Turi G.F.; Coen C.W.; Greenfield S.A.; Histamine H3 receptors inhibit serotonin release in substantia nigra pars reticulata. J Neurosci 2004,24(40),8704-8710","journal-title":"J Neurosci"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1111\/j.1471-4159.2008.05532.x","volume":"106","author":"He G.","year":"2008","unstructured":"He G.; Hu J.; Ma X.; Sympathetic histamine exerts different pre- and post-synaptic functions according to the frequencies of nerve stimulation in guinea pig vas deferens. J Neurochem 2008,106(4),1710-1719","journal-title":"J Neurochem"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1124\/jpet.108.137919","volume":"326","author":"Morrey C.","year":"2008","unstructured":"Morrey C.; Estephan R.; Abbott G.W.; Levi R.; Cardioprotective effect of histamine H3-receptor activation: Pivotal role of G beta gamma-dependent inhibition of voltage-operated Ca2+ channels. J Pharmacol Exp Ther 2008,326(3),871-878","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s00213-010-2092-4","volume":"214","author":"Galici R.","year":"2011","unstructured":"Galici R.; Rezvani A.H.; Aluisio L.; JNJ-39220675, a novel selective histamine H3 receptor antagonist, reduces the abuse-related effects of alcohol in rats. Psychopharmacology (Berl) 2011,214(4),829-841","journal-title":"Psychopharmacology (Berl)"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.neuropharm.2015.06.006","volume":"106","author":"Nuutinen S.","year":"2016","unstructured":"Nuutinen S.; M\u00e4ki T.; Rozov S.; Histamine H3 receptor antagonist decreases cue-induced alcohol reinstatement in mice. Neuropharmacology 2016,106,156-163","journal-title":"Neuropharmacology"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/0006-8993(96)00618-X","volume":"734","author":"Ito C.","year":"1996","unstructured":"Ito C.; Onodera K.; Sakurai E.; Sato M.; Watanabe T.; The effect of methamphetamine on histamine level and histidine decarboxylase activity in the rat brain. Brain Res 1996,734(1-2),98-102","journal-title":"Brain Res"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1440-1819.1997.tb02911.x","volume":"51","author":"Ito C.","year":"1997","unstructured":"Ito C.; Onodera K.; Yamatodani A.; Watanabe T.; Sato M.; The effect of methamphetamine on histamine release in the rat hypothalamus. Psychiatry Clin Neurosci 1997,51(2),79-81","journal-title":"Psychiatry Clin Neurosci"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"R704","DOI":"10.1152\/ajpregu.00114.2014","volume":"307","author":"John J.","year":"2014","unstructured":"John J.; Kodama T.; Siegel J.M.; Caffeine promotes glutamate and histamine release in the posterior hypothalamus. Am J Physiol Regul Integr Comp Physiol 2014,307(6),R704-R710","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1159\/000137343","volume":"20","author":"Subramanian N.","year":"1980","unstructured":"Subramanian N.; Schinzel W.; Mitznegg P.; Estler C.J.; Influence of ethanol on histamine metabolism and release in the rat brain. II. Regions of the histaminergic pathway. Pharmacology 1980,20(1),42-45","journal-title":"Pharmacology"},{"key":"ref=101","first-page":"291","volume":"23","author":"Muley M.P.","year":"1979","unstructured":"Muley M.P.; Balsara J.J.; Chandorkar A.G.; Effect of L-histidine pretreatment on methamphetamine induced sterotyped behaviour in rats. Indian J Physiol Pharmacol 1979,23(4),291-296","journal-title":"Indian J Physiol Pharmacol"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s40263-020-00703-x","volume":"34","author":"Lamb Y.N.","year":"2020","unstructured":"Lamb Y.N.; Pitolisant: A review in narcolepsy with or without cataplexy. CNS Drugs 2020,34(2),207-218","journal-title":"CNS Drugs"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1080\/17512433.2020.1714435","volume":"13","author":"Li S.","year":"2020","unstructured":"Li S.; Yang J.; Pitolisant for treating patients with narcolepsy. Expert Rev Clin Pharmacol 2020,13(2),79-84","journal-title":"Expert Rev Clin Pharmacol"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1017\/S0022215100082785","volume":"90","year":"1976","unstructured":"Wilmot TJ, Menon GN. Betahistine in M\u00e9ni\u00e8re\u2019s disease. J Laryngol Otol 1976,90(9),833-840","journal-title":"J Laryngol Otol"},{"key":"ref=105","first-page":"CD010696","author":"Murdin L.","year":"2016","unstructured":"Murdin L.; Hussain K.; Schilder A.G.; Betahistine for symptoms of vertigo. Cochrane Database Syst Rev 2016(6),CD010696","journal-title":"Cochrane Database Syst Rev"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0014-2999(02)01795-8","volume":"446","author":"Tighilet B.","year":"2002","unstructured":"Tighilet B.; Trottier S.; Mourre C.; Chotard C.; Lacour M.; Betahistine dihydrochloride interaction with the histaminergic system in the cat: Neurochemical and molecular mechanisms. Eur J Pharmacol 2002,446(1-3),63-73","journal-title":"Eur J Pharmacol"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.biopha.2018.01.160","volume":"100","author":"Kitanaka N.","year":"2018","unstructured":"Kitanaka N.; Kitanaka J.; Hall F.S.; Psychotomimetic-like behavioral effects of memantine in the mouse. Biomed Pharmacother 2018,100,116-123","journal-title":"Biomed Pharmacother"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S0091-3057(01)00691-8","volume":"71","author":"Malmberg-Aiello P.","year":"2002","unstructured":"Malmberg-Aiello P.; Ipponi A.; Bartolini A.; Schunack W.; Mouse light\/dark box test reveals anxiogenic-like effects by activation of hista-mine H1 receptors. Pharmacol Biochem Behav 2002,71(1-2),313-318","journal-title":"Pharmacol Biochem Behav"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0304-3940(00)01176-9","volume":"288","author":"Malmberg-Aiello P.","year":"2000","unstructured":"Malmberg-Aiello P.; Ipponi A.; Bartolini A.; Schunack W.; Antiamnesic effect of metoprine and of selective histamine H(1) receptor agonists in a modified mouse passive avoidance test. Neurosci Lett 2000,288(1),1-4","journal-title":"Neurosci Lett"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/PL00004954","volume":"355","author":"Malmberg-Aiello P.","year":"1997","unstructured":"Malmberg-Aiello P.; Lamberti C.; Ipponi A.; H\u00e4nninen J.; Ghelardini C.; Bartolini A.; Effects of two histamine-N-methyltransferase inhibitors, SKF 91488 and BW 301 U, in rodent antinociception. Naunyn Schmiedebergs Arch Pharmacol 1997,355(3),354-360","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"}],"container-title":["Current Drug Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/2589977514666220414122847","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/203585\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/2589977514666220414122847","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T15:58:27Z","timestamp":1669305507000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/203585\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":110,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/2589977514666220414122847","relation":{},"ISSN":["2589-9775"],"issn-type":[{"value":"2589-9775","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-10-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-21","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-31","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}